157 E 32nd St. New York, NY 10016 212-689-6791
Array
(
    [0] => 2773
    [1] => 2772
    [2] => 2771
    [3] => 2770
)

FDA Approves Nivolumab for Advanced Non-Squamous NSCLC
Cancer Network
October, 2015
http://www.cancernetwork.com/lung-cancer/fda-approves-nivolumab-advanced-non-squamous-nsclc

A Novel Antibody-Drug Conjugate for Lung Cancer: An interview with Dr. Camidge from University of Colorado about an early stage lung cancer trial of IMMU-132.
Cancer Network
September, 2015
http://www.cancernetwork.com/wclc-2015/novel-antibody-drug-conjugate-chemotherapy-future-lung-cancer

Afatinib plus cetuximab shows promise in EGRF-mutated lung cancer
HemOnc Today
July 31, 2014
http://www.healio.com/hematology-oncology/lung-cancer/news/online/%7B71099a79-b4ea-477b-8d6b-941b9fcba816%7D/afatinib-plus-cetuximab-shows-promise-for-egfr–mutated-lung-cancer

Astrazeneca spartners with Roche, Qiagen for co-development of lung cancer diagnostics
Tech Times
July 30, 2014
http://www.techtimes.com/articles/11508/20140730/astrazeneca-partners-with-roche-qiagen-for-co-development-of-lung-cancer-diagnostics.htm

Treatment Combo for EGFR Inhibitor-Resistant Lung Cancer
Cancer Network
July 29, 2104
http://www.cancernetwork.com/lung-cancer/treatment-combo-egfr-inhibitor-resistant-lung-cancer

Drug Candidate AZD3965 Slows Tumor Growth
HealthLine
July 16, 2014
http://www.healthline.com/health-news/emerging-treatments-for-small-cell-lung-cancer-071614